NCT07446491: A Study to Evaluate the Safety and Efficacy of PN20 in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure

Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd.. Phase: PHASE1. Conditions: Thrombocytopenia Associated With Chronic Liver Disease